As per the U.S. District Court, District of New Jersey court order released on June 20, 2018, the first bellwether trial for the kidney injury lawsuits against Nexium and other PPI manufacturers will convene on September 21, 2020.
Over 4,500 lawsuits are federally-filed against PPI manufacturers over claims that the heartburn drugs Nexium, Prilosec, Prevacid, Protonix, and Dexilant cause kidney complications. Plaintiffs accuse the drug makers of failing to provide adequate warnings to doctors and patients about the potential risks of the drugs. Lawsuits claim adverse events of renal malfunctions including Acute interstitial nephritis, Acute kidney injury, Chronic kidney disease, and Kidney failure. PPI lawsuits were centralized as part of the multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation |LS|No. II|RS|) overlooked by Judge Claire C. Cecchi in the District of New Jersey.
